You searched for "ChatGPT"

941 results found

Charity work in Cambodia: Culture, cataracts, and cruelty

Cambodia has one of the lowest numbers of eye specialist doctors per capita in the world, and Bita Manzouri takes us on a journey into the charitable work of the Khmer Sight Foundation who are working to combat this. “Ut...

See sweet to C-suite: Peter Holland

See also - See sweet to C-suite: Imran Rahman In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part One: David speaks...

Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy

COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...

The Story of Looking: Mark Cousins

Lake, Sweden, as featured in The Story Of Looking. In an interview with Director Mark Cousins about his relationship with sight and storytelling, Peter Cackett discusses Cousins’ recent film, The Story of Looking, and how its production informed, and was...

Infection prevention and control through a VISION 2020 LINK between Mombasa and Southampton

The authors share how a partnership between Mombasa and Southampton has enabled Kenyan healthcare professionals from four institutions to innovate and work as a group to improve infection prevention and control. Infection prevention and control (IPC) is a cornerstone of...

Strengthening capacity for ophthalmic research within three East African VISION 2020 LINKS – The Research Mentorship Workshop

Building capacity for ophthalmic research in low- and middle-income countries is an important aim of the VISION 2020 LINKS Programme. The International Centre for Eye Health (ICEH) at the London School of Hygiene & Tropical Medicine (LSHTM) has been working...

VISION 2020 LINKS Programme: Reviewing the first ten years and announcing the new diabetic retinopathy initiative

The VISION 2020 LINKS Programme celebrates its 10th anniversary next month. Over the past decade it has achieved its objective of building capacity for eye care in developing countries, particularly in Africa, by establishing long-term training partnerships between institutions, known...

The Diabetic Eye Screening Programme in Tanzania - The VISION 2020 LINK between Dodoma and Belfast

Rahila Bashir, Senior Remote Ophthalmic Research Image Grader, talks to Frank Sandi, Ophthalmologist at the Benjamin Mkapa Hospital (BMH), University of Dodoma in Tanzania and to Tunde Peto at Queen’s University Belfast (QUB) and Belfast Health and Social Care Trust...

Technology in ophthalmology – a promising future and what we need to know about the regulations

Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...

The paediatric cataract: an overview of the embryology and pathophysiology

In the first of the two articles (see Part 2 here) on paediatric cataracts, Samuel Aryee reviews the aetiology of this condition. Cataracts arise from opacification of the natural transparent lens, which can cause partial or total blindness. Although the...

Optical coherence tomography – reinventing the eye examination

It has been 25 years since Huang et al. presented the first optical coherence tomography (OCT) images in Science [1]. With vast improvements in OCT technology over the years, it is now possible to acquire high-resolution cross-sectional images of the...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...